Cagrilintide
Amylin analog. Often researched alongside GLP-1 compounds for synergistic effects.
For research use only · Not for human consumption
Every source for Cagrilintide
Affiliate disclosure: purchases through links below may earn us a commission. Rankings are never sold — methodology · full disclosure
- ✓Third-party tested (Janoshik)
- ✓COAs provided — Per-batch
- ✓Within 15% of cheapest, higher verification tier
- ✓4.8★ community rating
The research base
Phase 2 trials show strong metabolic effects. Amylin pathway adds to GLP-1 effects.
How it works
Amylin receptor agonist. Slows gastric emptying, reduces appetite via different pathway than GLP-1.
Common research protocols
Amylin analog often paired with semaglutide (CagriSema) or tirzepatide. Adds satiety and slows gastric emptying via different pathway than GLP-1. Increases GI side effects when combined with GLP-1s — slow titration essential.
As a solo compound
Effective standalone. Amylin pathway is independent of GLP-1.
What to know
Common: GI adjustment.
Realistic expectations
Effects within 4-8 weeks
